Drug
Hydroxychloroquine Sulfate 200 MG
Hydroxychloroquine Sulfate 200 MG is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Withdrawn2
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
completed125%
withdrawn250%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
NCT03377179
withdrawnphase_2
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
NCT04389359
withdrawnphase_2
Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
NCT04354441
unknownphase_2
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537
Clinical Trials (4)
Showing 4 of 4 trials
NCT03377179Phase 2
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
NCT04389359Phase 2
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
NCT04354441Phase 2
Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
NCT04359537Phase 2
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4